Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Completed

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

NCT04943380

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Veterans Medical Research Foundation San Diego, California, United States
  • Bay Pines Veterans Affairs Bay Pines, Florida, United States
  • South Florida Veterans Affairs Miami, Florida, United States
  • James A Haley Veterans' Hospital Tampa, Florida, United States
View Trial Details
Completed

A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

NCT04822350

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • CHU Charles Nicolle Rouen, Haute-normandie, France
  • CHU Nantes Nantes, Pays de la Loire Region, France
  • Centre Hospitalier du Pays d AIX Aix-en-Provence, France
  • CHU Amiens-Picardie Amiens, France
View all 81 locations
View Trial Details
Completed

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

NCT03898180

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0016) Gilbert, Arizona, United States
  • Community Cancer Institute ( Site 0777) Clovis, California, United States
  • University of California Irvine Medical Center ( Site 0078) Orange, California, United States
  • John Wayne Cancer Institute ( Site 0017) Santa Monica, California, United States
View all 194 locations
View Trial Details
Completed

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

NCT02989064

Conditions
Bladder Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Completed

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

NCT03869190

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
View all 33 locations
View Trial Details
Completed

Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas

NCT04566029

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • ICM parc euromedecine Montpellier, Hérault, France
  • Hopital Tenon ( Paris) Paris, Paris Cx 20, France
  • Institut Sainte Cancerologie Lucien Neuwirth Avignon, Saint Priest En Jarez, France
  • ICO-Site Paul Papin Angers, France
View Trial Details
Completed

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

NCT04344795

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +41 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Baystate Gynecologic Oncology Springfield, Massachusetts, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions